New Study Reveals Promising Outcomes for Minimally Invasive Sacrospinous Ligament Fixation Using EnPlace® for Treating Pelvic Organ Prolapse in Older Women
October 17, 2024 10:00 ET | FEMSelect Ltd.
NEWARK, Del., Oct. 17, 2024 (GLOBE NEWSWIRE) -- A new study published last week in the “Journal of Clinical Medicine” has revealed promising results for sacrospinous ligament (SSL) fixation using...
FEMSelect Launches Consumer Advocacy Campaign To Raise Awareness and Highlight Treatment Options for Pelvic Organ Prolapse
August 03, 2023 13:00 ET | FEMSelect Ltd.
NEWARK, Del., Aug. 03, 2023 (GLOBE NEWSWIRE) -- FEMSelect Ltd., a women-led company developing groundbreaking solutions to advance women's health, today announced the launch of its Consumer Advocacy...
Picture1.jpg
LevLane Advertising Appointed Agency of Record by FEMSelect Ahead of Consumer Advocacy Campaign
June 22, 2023 10:00 ET | LevLane
PHILADELPHIA, June 22, 2023 (GLOBE NEWSWIRE) -- FEMSelect, a women's health company dedicated to providing safe and effective health solutions, has appointed award-winning LevLane Advertising as its...